• Explore /
  • Poster
  • / SAKK 08/15-promet: Multicenter, randomized phase II trial of salvage radiotherapy +/- metformin for patients with prostate cancer after prostatectomy.

SAKK 08/15-promet: Multicenter, randomized phase II trial of salvage radiotherapy +/- metformin for patients with prostate cancer after prostatectomy.

Abstract Poster

Authors

null

Alan Dal Pra

Inselspital, Bern University Hospital and University of Bern/ University of Miami Miller School of Medicine, Bern, Switzerland

Alan Dal Pra , Pirus Ghadjar , Stephane Supiot , Aurelius Gabriel Omlin , Stefanie Hayoz , Daniel Rudolf Zwahlen , Michael N. Pollak , Silke Gillessen , Daniel M. Aebersold

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 Genitourinary Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session A: Prostate Cancer

Track

Prostate Cancer,Prostate Cancer

Sub Track

Prostate Cancer - Localized Disease

Clinical Trial Registration Number

NCT02945813

Citation

J Clin Oncol 36, 2018 (suppl 6S; abstr TPS157)

DOI

10.1200/JCO.2018.36.6_suppl.TPS157

Abstract #

TPS157

Poster Bd #

N20

Abstract Disclosures

Similar Posters

First Author: Alan Dal Pra

First Author: Tian Zhang

Poster

2023 ASCO Genitourinary Cancers Symposium

Metformin for biochemical recurrence of prostate cancer: Immune data from a phase 2 study.

Metformin for biochemical recurrence of prostate cancer: Immune data from a phase 2 study.

First Author: Marijo Bilusic

First Author: Phuoc T. Tran